Abstract
ABSTRACT. In recent years, there has been an increase in the number of cases of combined HIV/TB/VH (human immunodeficiency virus / tuberculosis / viral hepatitis) infection. Approaches to the treatment of these patients are changing with the advent of antiviral drugs for the treatment of hepatitis B and C. Treatment of VH in patients with TB increases the effectiveness of antituberculosis therapy by reducing the hepatotoxicity of antimycobacterial drugs. The interaction of antituberculosis, antiretroviral, and direct-acting antiviral drugs for the treatment of HCV was taken into account when managing a case of HIV/TB/HV. The article presents a case of effective treatment of a patient with combined HIV/TB/VH infection.
Publisher
Communicable Diseases Intensive Care Association
Reference6 articles.
1. Nakaz MOZ Ukrainy № 51 vid 15.01.2021: Standarty medychnoyi dopomogy “Virusnyi gepatyt C”, 25 p.
2. Nakaz MOZ Ukrainy № 49 vid 15.01.2021: Standarty meduchnoyi dopomogy “Virusnyi gepatyt B”, 31 p.
3. Friedland G. Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis. J. Acquir. Immune Defic. Syndr. 2010 Dec; 55: 37-42.
4. Ghany M.G., Morgan T.R. Hepatitis C guidance 2019 update: Ameican Association for the Study of Liver Diseases – Infectious Dieases Society of America recommendations for testing, mana-ging, and treating hepatitis C virus infection. Hepatology. 2020; 71 (2): 686721. doi: 101002/hep.31060.
5. Pawlotsky J., Negro F., Aghemo Berenguer M., Dalgard O., Dusheiko G., et al. EASL recommendations on treatment of hepatitis C 2018. Journal of Hepatology. 2018; 69 (2): 461-511.doi: 10/1016/j.jhep.2018.03.026.